{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:15:17Z","timestamp":1775715317983,"version":"3.50.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"9-10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Diabetes is a growing epidemic worldwide and among our active duty population, posing a significant threat to maintaining military health and operational readiness. Latent autoimmune diabetes in adults (LADA) is a growing clinical phenotype of diabetes, with overlap between traditional type 1 diabetes mellitus and type 2 diabetes mellitus. In this case, a 27-year-old active duty male presented with polydipsia, polyuria, polyphagia, and recent weight loss. He was diagnosed with LADA, placed on a period of limited duty status and started on insulin. Eight months after diagnosis, he was transitioned from insulin to a glucagon-like peptide-1 receptor agonist in an effort to be returned to full duty status and worldwide deployable. Over 3\u00a0years after initial diagnosis, he has achieved partial clinical remission. He remains on active duty, serving on a medically limited platform with a single medication (a glucagon-like peptide-1 receptor agonist) and high compliance with a gluten-free, low-carbohydrate diet and regular exercise. One should consider the diagnosis of LADA and its unique management, especially in the younger active duty population. Not only is making the correct diagnosis regarding the type of diabetes critical in regard to prognosis and optimal medical management, but it can affect the ability of military members to remain on active duty.<\/jats:p>","DOI":"10.1093\/milmed\/usaa012","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T13:16:30Z","timestamp":1588770990000},"page":"e1843-e1846","source":"Crossref","is-referenced-by-count":2,"title":["Correct Diabetes Diagnosis and Treatment Allows Sailor to Remain on Active Duty"],"prefix":"10.1093","volume":"185","author":[{"given":"Andrea R","family":"Frazier","sequence":"first","affiliation":[{"name":"Medical Readiness Division, Naval Surface Squadron FOURTEEN, Naval Station Mayport, P.O. Box 280158 Jacksonville, FL 32228"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"Suppl. 1","key":"2020092112042930700_ref1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes--2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"2020092112042930700_ref2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2018.0190","article-title":"Latent autoimmune diabetes in adults: a review on clinical implications and management","volume":"42","author":"Pieralice","year":"2018","journal-title":"Diabetes Metab J"},{"issue":"11","key":"2020092112042930700_ref3","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.2337\/diacare.24.11.1894","article-title":"Weighing in on type 2 diabetes in the military. Characteristics of US military personnel at entry who develop type 2 diabete","volume":"24","author":"Paris","year":"2001","journal-title":"Diabetes Care"},{"key":"2020092112042930700_ref4","first-page":"219","volume-title":"Type 1 Diabetes: Molecular, Cellular and Clinical Immunology","author":"Rewers","edition":"2nd"},{"key":"2020092112042930700_ref5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-319-45015-5_9","volume-title":"Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment","author":"Zampetti","year":"2018"},{"key":"2020092112042930700_ref6","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","article-title":"Latent autoimmune diabetes in adults (LADA) should be less latent","volume":"48","author":"Fourlanos","year":"2005","journal-title":"Diabetologia"},{"issue":"3","key":"2020092112042930700_ref7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1745-7599.2009.00399.x","article-title":"Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus","volume":"21","author":"Appel","year":"2009","journal-title":"J Am Acad Nurse Pract"},{"key":"2020092112042930700_ref8","article-title":"Misdiagnosis of latent autoimmune diabetes in adults","author":"Hashmi"},{"issue":"9","key":"2020092112042930700_ref9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tem.2018.07.001","article-title":"A global perspective of latent autoimmune diabetes in adults","volume":"29","author":"Mishra","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"2020092112042930700_ref10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2337\/diacare.24.8.1460","article-title":"Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization and potential prevention","volume":"24","author":"Pozzilli","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"2020092112042930700_ref11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/jc.2005-1623","article-title":"Clinical review: type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow","volume":"91","author":"Leslie","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020092112042930700_ref12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2337\/dc05-2101","article-title":"A clinical screening tool identifies autoimmune diabetes in adults","volume":"29","author":"Fourlanos","year":"2006","journal-title":"Diabetes Care"},{"key":"2020092112042930700_ref13","first-page":"16","article-title":"Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3","volume":"2016","author":"Pinheiro","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1(Suppl)","key":"2020092112042930700_ref14","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9600.C1.039","article-title":"\u201cRemission of latent autoimmune diabetes of adulthood via holistic approach.\u201d 9th International Congress on Nutrition & Health","volume":"7","author":"Millis","year":"2017","journal-title":"J Nutr Food Sci"},{"key":"2020092112042930700_ref15","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-15-0136","article-title":"Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults","volume":"2016","author":"Rapti","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"2020092112042930700_ref16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/ds15-0047","article-title":"Recognizing and appropriately treating latent autoimmune diabetes in adults","volume":"29","author":"O\u2019Neal","year":"2016","journal-title":"Diabetes Spectr"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/185\/9-10\/e1843\/33765697\/usaa012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/185\/9-10\/e1843\/33765697\/usaa012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:13:32Z","timestamp":1600704812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/185\/9-10\/e1843\/5830793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":16,"journal-issue":{"issue":"9-10","published-online":{"date-parts":[[2020,5,6]]},"published-print":{"date-parts":[[2020,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaa012","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,5,6]]}}}